Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma.
Journal: Journal of gastrointestinal oncology
Published: January 05, 2018
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 04, 2013
Phase 1 study of N(1),N(11)‑diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.
Journal: Cancer chemotherapy and pharmacology
Published: July 19, 2013
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 11, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026